News Polsky Science and Technology Associates Helping Drive University Innovation Forward The new cohort of the Polsky Science and Technology Associates includes three University of Chicago graduate students who are working with the Polsky Center’s technology and business development teams to...
News The Polsky Center Collaborates with the India Deep Tech Alliance to Launch the India Deep Tech Accelerator The new collaboration will help deep tech founders in the Indian Institutes of Technology (IIT) translate breakthrough innovation into globally competitive companies through the newly established India Deep Tech Accelerator...
News Winter 2026 Collaboratorium Connects Scientific Breakthroughs with Business Insight Bringing together cutting-edge research and real-world business expertise, the Winter 2026 Collaboratorium will feature ventures spanning photonic computing, advanced therapeutics, energy, materials science, and artificial intelligence from across the Midwest...
News George Shultz Innovation Fund Announces 4 Finalists Pitching for Potential Investment The 2026 George Shultz Innovation Fund finalists are developing novel software, medical devices, and therapeutics. Managed by the Polsky Center for Entrepreneurship and Innovation, the George Shultz Innovation Fund provides up to...
News The Coasts Don’t Own Innovation. They Just Own the Capital. Innovation is no longer confined to a few coastal cities. We know that well in the Midwest. Across the region, our universities, research labs, and entrepreneurs are launching companies in...
Technology A Low Dose, Multi-drug Cocktail for the Treatment of Metastatic and Resistant Breast Cancers An estimated 20-30% of breast cancer patients suffer from metastatic recurrence, which can be perpetuated by an overreliance on high doses of a single drug during initial treatment. In addition…
Technology Genetic Engineering Tools To Stimulate And Enhance The Production Of Select Compounds From Bacterial Species Synthetic biology toolsets to genetically manipulate the microbiota, specifically non-model resident gut microbes, to alter gene expression and cellular function to produce therapeutic compounds. Unmet Need: Genetic engineering tools for…
Technology Novel Platform for Allosterically Modifying Enzyme Specificty Fine tuning enzyme specificity is desired for industrial catalysis. Enzymes lacking structural characterization or favorable recombinant expression are not amenable to traditional directed evolution or de novo design approaches. “Monobodies”…
Technology Programmable And Hyperstable Engineered Synthetic Transcriptional Repressors A class of functionally enhanced synthetic transcriptional factor antagonists to modulate the MYC/MAX transcriptional network by direct competition for DNA binding. The Unmet Need: Transcription factors remain largely untapped as…
Technology Low-Input Methylation Sequencing For Profiling Epitranscriptomic Signatures And Early Colorectal Cancer Diagnosis A method that analyzes cfRNA methylation in plasma to distinguish human RNA from microbiome RNA, accurately detecting colorectal cancer through specific methylation markers even in ultralow input samples. The Unmet…
News Enemsa Pharma Secures Rights from UChicago to Develop Novel Therapeutic Enemsa Pharma has been granted exclusive patent rights from the University of Chicago to use a family of small molecules for the treatment of demyelinating diseases.
Page Technology Emerging technologies that redefine industries and expand the frontiers of innovation.
